Trend

Last Previous Currency Date Chng
97.05 94.86 USD 25/12/22 +2.31

Terms

Isin LU0195948822
Contract Type Sicav
Currency USD
Class I
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech
Start Date 04/08/31
Advisor Name Evan McCulloch; Vincent Xiang
Fund Asset Under Management N.Av.

Performance

Cumulatives
1 month +2.04
Ytd +34.16
1 year +34.47
3 years +69.74
5 years +40.50
Yearly
11/30/2024 +10.10
11/30/2023 +14.18
11/30/2022 -6.31
11/30/2021 -9.70
11/30/2020 +17.78
Rating
N.Av.
Score
N.Av.

Company

Franklin Templeton Intern Serv
8A, rue Albert Borschette L-1246 - Lussemburgo
Tel. N.Av.

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 0.7
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial 5000000,0000 USD
Integrative 1000,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 5000000,0000

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 0.7
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day +1.97
1 week -1.00
1 month +2.04
3 months +30.89
6 months +55.11
From the beginning of the year +34.16
1 year +34.47
2 years +54.46
3 years +69.74
4 years +59.34
5 years +40.50
Yearly
11/30/2024 +10.10
11/30/2023 +14.18
11/30/2022 -6.31
11/30/2021 -9.70
11/30/2020 +17.78


Rating
N.Av.
Score
N.Av.

Efficiency Indicators

Sharpe 1 year 0.7221
Benchmark 1 year N.Av.
Sharpe 3 years 0.6199
Benchmark 3 years N.Av.
Sharpe 5 years 0.4095
Benchmark 5 years N.Av.
Sortino 1 year 1.4453
Benchmark 1 year N.Av.
Sortino 3 years 1.2509
Benchmark 3 years N.Av.
Sortino 5 years 0.728
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +25.68
3 years +20.52
5 years +19.32
Negative Volatility
1 year +12.91
3 years +10.16
5 years +10.81

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 25/11/28

Relative

Sharpe 0.6199
Sortino 1.2509
Bull Market +10.82
Bear Market -4.02
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,746 3 years 15,635 5 years 13,875
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,746
4,277
  
+32.24
3 years 15,635
4,945
  
+63.98
5 years 13,875
8,980
  
+49.68
Performance
4,277 +32.24 4,945 +63.98 8,980 +49.68
Total Volatility
1 year 17,746
20,784
  
+25.68
3 years 15,635
16,922
  
+20.52
5 years 13,875
13,833
  
+19.32
Total Volatility
20,784 +25.68 16,922 +20.52 13,833 +19.32
Negative Volatility
1 year 17,746
17,705
  
+12.91
3 years 15,635
16,896
  
+10.16
5 years 13,875
13,918
  
+10.81
Negative Volatility
17,705 +12.91 16,896 +10.16 13,918 +10.81
Sharpe Index
1 year 17,746
16,553
  
+0.72
3 years 15,635
12,374
  
+0.62
5 years 13,875
11,190
  
+0.41
Sharpe Index
16,553 +0.72 12,374 +0.62 11,190 +0.41
Sortino Index
1 year 17,746
12,790
  
+1.45
3 years 15,635
11,899
  
+1.25
5 years 13,875
11,207
  
+0.73
Sortino Index
12,790 +1.45 11,899 +1.25 11,190 +0.73

By Category

  1 year 17,746 3 years 15,635 5 years 13,875
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,746
44
  
+32.24
3 years 15,635
71
  
+63.98
5 years 13,875
61
  
+49.68
Performance
44 +32.24 71 +63.98 61 +49.68
Total Volatility
1 year 17,746
72
  
+25.68
3 years 15,635
73
  
+20.52
5 years 13,875
69
  
+19.32
Total Volatility
72 +25.68 73 +20.52 69 +19.32
Negative Volatility
1 year 17,746
70
  
+12.91
3 years 15,635
71
  
+10.16
5 years 13,875
67
  
+10.81
Negative Volatility
70 +12.91 71 +10.16 67 +10.81
Sharpe Index
1 year 17,746
58
  
+0.72
3 years 15,635
71
  
+0.62
5 years 13,875
61
  
+0.41
Sharpe Index
58 +0.72 71 +0.62 61 +0.41
Sortino Index
1 year 17,746
56
  
+1.45
3 years 15,635
71
  
+1.25
5 years 13,875
59
  
+0.73
Sortino Index
56 +1.45 71 +1.25 59 +0.73

Foreign Funds - Franklin Biotechnology Discovery I $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.